All In Biotech

Drug Trial Radar · NCT05741242

A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Last checked: Nov 20, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

136

Planned (sponsor's estimate)

Start

Nov 30, 2022

Primary completion

Jan 2027

Study completion Jan 2029

Sponsor

Lead sponsor
Jaime Leandro Foundation for Therapeutic Cancer VaccinesAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 23, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Conditions

  • Cancer
  • Solid Tumor

Interventions

  • Personalized Synthetic Long Peptide VaccineBiological

    Personalized Synthetic Long Peptide Vaccine

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the efficacy of NeoSLP vaccination by investigator assessment of Progression-Free Survival at 12 months (PFS12).Time frame: Until progression or death, assessed up to 12 months post first vaccine administration.

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Precision NextGen Oncology & Research Center

    Beverly Hills, California

  • Quest Clinical Research

    San Francisco, California

  • Asthra Health

    Santa Monica, California

  • Mount Sinai Comprehensive Cancer Center

    Miami Beach, Florida

  • St. Louis Cancer Care

    Bridgeton, Missouri

  • Anna Gattani MD PC

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.